Aktis Oncology, Inc. AKTS

19.43 (0.20) (1.02%) as of 25 Sep
Market cap
$1.1B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23
Cash and Short Term Investments
226.79 297.17 97.86
Total current assets
230.31 300.85 100.20
Property, Plant, Equpment (Net)
14.60 7.30 5.51
Long-term assets (Other)
7.33 4.46 1.23
Total non-current assets
34.58 25.33 22.15
Total Assets
264.89 326.18 122.36
Accounts Payable
1.74 1.92 0.96
Accrued Expenses
9.52 6.33 3.75
Current Revenue (Deferred)
18.66 9.28 —
Total current liabilities
31.24 18.82 6.24
Non-current Revenue (Deferred)
36.16 51.04 —
Liabilities (Preferred Stock)
— — 0.50
Total non-current liabilities
46.39 61.75 12.37
Total liabilities
77.63 80.58 18.61
Additional Paid In Capital
10.37 4.91 2.47
Preferred Stock (Total)
333.41 333.41 150.05
Common Stock (Net)
0.00 0.00 —
Retained Earnings
(156.56) (92.83) (48.85)
Common Equity (Total)
(146.15) (87.80) (46.31)
Shareholders Equity (Total)
187.26 245.61 103.74
Shareholders Equity and Liabilities (Total)
264.89 326.18 122.36
Shares (Common)
0.92 0.78 —
Shares (Preferred)
129.57 129.57 83.07
Shareholders Equity (Tangible)
187.26 245.61 103.74
Net Debt
(226.79) (297.17) (97.86)

Fold the line items

In millions of $ except per-share values · columns are period end dates